Cong‐Cong Wu
Impact in
-
- Cancer Research and Treatments
Papers in
-
- RNA modifications and cancer 4
-
- Galectins and Cancer Biology 3
- Co-authors
- Zhi‐Jun Sun (14 shared papers)Wei‐Wei Deng (3 shared papers)Yao Xiao (10 shared papers)Xian‐Zheng Zhang (2 shared papers)Diwei Zheng (2 shared papers)Wenfang Song (1 shared paper)Han Cheng (1 shared paper)Sheng Hong (1 shared paper)
In The Last Decade
Cong‐Cong Wu
23 papers receiving 392 citations
Peers
Comparison fields: 5 of 81
- Periodontics 15
- Biotechnology 30
- Immunology 63
- Pathology and Forensic Medicine 42
- Oncology 60
Countries citing papers authored by Cong‐Cong Wu
This map shows the geographic impact of Cong‐Cong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong‐Cong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong‐Cong Wu more than expected).
Fields of papers citing papers by Cong‐Cong Wu
This network shows the impact of papers produced by Cong‐Cong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong‐Cong Wu. The network helps show where Cong‐Cong Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong‐Cong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 125 | |
| 2 | 2024 | 50 | |
| 3 | 2018 | 44 | |
| 4 | 2019 | 21 | |
| 5 | 2018 | 21 | |
| 6 | 2019 | 18 | |
| 7 | 2022 | 17 | |
| 8 | 2019 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2021 | 14 | |
| 11 | 2018 | 11 | |
| 12 | 2019 | 10 | |
| 13 | 2025 | 9 | |
| 14 | 2020 | 5 | |
| 15 | [Correlation analysis of inflammatory response and Klotho expression in renal tissue of mice with acute renal injury induced by cisplatin]. | 2019 | 5 |
| 16 | 2020 | 3 | |
| 17 | 2021 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2022 | 1 |
About Cong‐Cong Wu
Cong‐Cong Wu is a scholar working on Molecular Biology, Immunology, Surgery, Oncology and Cancer Research, having authored 23 papers that have together received 392 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Galectins and Cancer Biology (3 papers), Peptidase Inhibition and Analysis (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Cell Adhesion Molecules Research (2 papers), Bone Tissue Engineering Materials (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Periodontics (15 citations), Biotechnology (30 citations), Immunology (63 citations), Pathology and Forensic Medicine (42 citations) and Oncology (60 citations). Cong‐Cong Wu has collaborated with scholars based in China, Malaysia and Australia. Frequent co-authors include Zhi‐Jun Sun, Wei‐Wei Deng, Yao Xiao, Xian‐Zheng Zhang, Diwei Zheng, Wenfang Song, Han Cheng, Sheng Hong, Jie Liu and Ze‐Nan Zhuang. Their work appears in journals such as Journal of Molecular Histology, Oral Diseases, Journal of Orthopaedic Surgery and Research, Disease Markers and European Journal Of Oral Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.